Value of PCNA and Ki67 staining in breast cancer.
Open Access
- 1 February 1993
- journal article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 46 (2) , 188-189
- https://doi.org/10.1136/jcp.46.2.188-c
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Relationship between interphase AgNOR distribution and nucleolar size in cancer cellsJournal of Molecular Histology, 1992
- Proliferating cell nuclear antigen is required for DNA excision repairCell, 1992
- Tumour suppressor gene products, proliferation, and differentiation markers in lung neuroendocrine neoplasmsThe Journal of Pathology, 1992
- Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parametersThe Prostate, 1992
- Effect of ionic strength in immunocytochemical detection of the proliferation associated nuclear antigens p120, PCNA, and the protein reacting with Ki‐67 antibodyCytometry, 1992
- The effect of tissue fixation on immunostaining for proliferating cell nuclear antigen with the monoclonal antibody PC10The Journal of Pathology, 1991
- Prognostic value of proliferating cell nuclear antigen in gastric carcinoma.Journal of Clinical Pathology, 1991
- Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: An index of cell proliferation with evidence of deregulated expression in some, neoplasmsThe Journal of Pathology, 1990
- How should we count AgNORS? Proposals for a standardized approachThe Journal of Pathology, 1989
- Silver‐binding nucleolar organizer regions (AgNORs) in benign and malignant breast lesions: Correlations with ploidy and growth phase by DNA flow cytometryThe Journal of Pathology, 1989